Briacell Therapeutics Corp.
BCTX and BCTXL • NASDAQ
Briacell Therapeutics Corp. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO William V. Williams, with a market cap of $27.2M.
CEOWilliam V. Williams
Next Earnings
Upcoming earnings announcement for Briacell Therapeutics Corp.
Date
Monday, June 15, 2026 (in 2 months)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q3 2026
Earnings History
Past 12 earnings reports for Briacell Therapeutics Corp.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Dec 11, 2025 | Q1 2026 | -$4.35Est: -$3.28 | -32.6% | -Est: $2.1M | -100.0% |  10-Q |
| Oct 16, 2025 | Q4 2025 | -$4.81Est: -$3.28 | -46.6% | -Est: $2.1M | -100.0% | 10-K |
| Jun 16, 2025 | Q3 2025 | -$1.64 | — | - | — | 10-Q |
| Mar 12, 2025 | Q2 2025 | -$2.33 | — | - | — | 10-Q |
| Dec 16, 2024 | Q1 2025 | -$3.30Est: -$4.50 | +26.7% | - | — | 10-Q |
| Oct 29, 2024 | Q4 2024 | -$1.05Est: -$7.80 | +86.5% | - | — | 10-K |
| Jun 14, 2024 | Q3 2024 | $1.65Est: -$8.25 | +120.0% | - | — | 10-Q |
| Mar 18, 2024 | Q2 2024 | -$10.65Est: -$3.00 | -255.0% | - | — | 10-Q |
| Dec 14, 2023 | Q1 2024 | -$7.50 | — | - | — | — |
| Oct 25, 2023 | Q4 2023 | -$2.25 | — | - | — | 10-K |
| Jun 14, 2023 | Q3 2023 | -$4.80Est: -$7.05 | +31.9% | - | — | — |
| Mar 16, 2023 | Q2 2023 | -$11.55Est: -$5.55 | -108.1% | - | — | — |